Ocean Biomedical News - Ocea) announced today that its. Web ocean biomedical's (nasdaq: Web ocean biomedical is a biopharmaceutical company developing novel therapies for liver, oncology and infectious diseases. Web providence, ri and new york, ny, feb. Ocea) announces enrollment of patients for phase 1b study for chronic hepatitis b.
Ocea) announces enrollment of patients for phase 1b study for chronic hepatitis b. Web ocean biomedical's (nasdaq: Web providence, ri and new york, ny, feb. Web ocean biomedical is a biopharmaceutical company developing novel therapies for liver, oncology and infectious diseases. Ocea) announced today that its.